A drug discovery program starts when a disease or clinical condition has no suitable drugs. In response, the pharmaceutical industry and academic research groups can follow different processes aimed at identifying new molecules with drug-like properties that efficiently modulate the desired biological target. These new chemical entities can be isolated from natural sources or obtained by chemical synthesis, as demonstrated by the articles and review papers reported in this Special Issue.

Biological Activity of Natural and Synthetic Compounds

Granchi, Carlotta
Ultimo
2022-01-01

Abstract

A drug discovery program starts when a disease or clinical condition has no suitable drugs. In response, the pharmaceutical industry and academic research groups can follow different processes aimed at identifying new molecules with drug-like properties that efficiently modulate the desired biological target. These new chemical entities can be isolated from natural sources or obtained by chemical synthesis, as demonstrated by the articles and review papers reported in this Special Issue.
2022
Granchi, Carlotta
File in questo prodotto:
File Dimensione Formato  
molecules-27-03652.pdf

accesso aperto

Tipologia: Versione finale editoriale
Licenza: Creative commons
Dimensione 190.83 kB
Formato Adobe PDF
190.83 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11568/1148480
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 1
social impact